FDA De Novo Classification Strategy

Why E&E Medicals Was Chosen

Developing a first-of-its-kind medical technology requires more than technical excellence — it demands a regulatory strategy capable of transforming innovation into an approvable product.

E&E Medicals provided strategic leadership by integrating FDA regulatory science, software quality, clinical evidence generation, risk management, and business planning into a unified commercialization program.

Through careful pathway selection, proactive FDA engagement, rigorous documentation, and disciplined project management, E&E Medicals helped the client to introduce a novel medical technology while establishing the regulatory foundation for future innovation.

His professional website provides a central overview of his work, while dedicated sections for ventures, projects, and professional publications provide additional insight into his professional interests and activities.

Learn More About Dr. Ebot Eyong and E&E Medicals

To explore his professional work, visit Dr. Ebot Eyong’s official website and learn more about E&E Medicals and Consulting.

You can also explore the company’s healthcare and regulatory ecosystem through eeMeds™, E&E Medical Supply, and the company’s wider professional resources